A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Novartis
Novartis
Dana-Farber Cancer Institute
Celgene
Celgene
Acrotech Biopharma Inc.
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Indiana University
Children's Oncology Group
Memorial Sloan Kettering Cancer Center
Duke University
National Institutes of Health Clinical Center (CC)
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium